-
Follow the Money: Inflammatory Bowel Disease Oral Drug, Breast, Colorectal Cancer ADCs, Other Next-Gen, Novel Treatments
Bio-IT World | NewLimit plans to launch its first human clinical trial next year, testing a liver cell-reprogramming therapy; SonoThera advances its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic; Portal’s platform uses mechanoporation to deliver materials such as RNA, gene editors, probes, and antibodies; and more.
Jul 1, 2026
-
Anthropic Launches Claude Science, Illumina's Spatial Insights Tool, Wellcome Sanger Institute, Google DeepMind AI Consortium
Bio-IT World | Hartwig Medical Foundation and Ultima Genomics expand their strategic collaboration; Thermo Fisher launches its Invitrogen E-Gel Power Snap Lite Electrophoresis System; the Pistoia Alliance announces the next phase of its Identification of Medicinal Products Ontology; and more.
Jun 30, 2026
-
The Spatial Biology Bottleneck: Why AI Models Fail on Complex Tissue & What Actually Fixes It
Bio-IT World | The life sciences industry has spent years optimizing AI architectures for cell segmentation and generating benchmark comparisons that demonstrate impressive performance on clean, standardized tissues. Yet far less energy has gone into the one question that actually determines whether a model can handle unique morphology: does the training data reflect the structural complexity the model will encounter in the real world?
Jun 26, 2026
-
Every Microbiome Tells a Changeable, Computable Story
Bio-IT World | People are not only human but also microbial, a summation largely of the choices they make: their social interactions, the food they eat, medications they take, their activity level, and daily habits. The microbes that are transmissible person-to-person are sometimes beneficial, but the odds are slightly better that they are causing harm.
Jun 24, 2026
-
Notes from the Trenches: A Computational Biologist’s View of Drug Discovery’s Digital Revolution
Bio-IT World | When Eleanor Howe took the stage at Bio-IT World Conference & Expo 2026 to deliver the annual “Trends from the Trenches” address, she arrived with a clear mandate: no buzzwords, no vendor spin, and no marketing varnish. She built this year’s Trends from the Trenches session from hours of interviews with colleagues, clients, and trusted advisors across the life sciences sector, delivering a wide-ranging, candid survey of where the field actually stands and what she predicts lies ahead.
Jun 23, 2026


